Richard B. Lanman

17.0k total citations · 4 hit papers
193 papers, 8.0k citations indexed

About

Richard B. Lanman is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Richard B. Lanman has authored 193 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Cancer Research, 110 papers in Pulmonary and Respiratory Medicine and 70 papers in Oncology. Recurrent topics in Richard B. Lanman's work include Cancer Genomics and Diagnostics (145 papers), Lung Cancer Treatments and Mutations (87 papers) and Genetic factors in colorectal cancer (61 papers). Richard B. Lanman is often cited by papers focused on Cancer Genomics and Diagnostics (145 papers), Lung Cancer Treatments and Mutations (87 papers) and Genetic factors in colorectal cancer (61 papers). Richard B. Lanman collaborates with scholars based in United States, Canada and South Korea. Richard B. Lanman's co-authors include Rebecca J. Nagy, Kimberly C. Banks, Giulia C. Kennedy, Lyssa Friedman, Victoria M. Raymond, Darya Chudova, Justin I. Odegaard, Juan Rosaí, Virginia A. LiVolsi and AmirAli Talasaz and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Richard B. Lanman

181 papers receiving 7.8k citations

Hit Papers

Preoperative Diagnosis of Benign Thyroid Nodules with Ind... 2012 2026 2016 2021 2012 2015 2019 2018 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
    2012 791 citations Darya Chudova, Richard B. Lanman et al. profile →
  2. Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
    2015 470 citations Richard B. Lanman, Stefanie Mortimer et al. profile →
  3. Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer
    2019 408 citations Natasha B. Leighl, Ray D. Page et al. Clinical Cancer Research profile →
  4. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients
    2018 271 citations Oliver A. Zill, Kimberly C. Banks et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard B. Lanman United States 47 4.0k 3.7k 3.2k 2.0k 1.8k 193 8.0k
Lori J. Wirth United States 48 961 0.2× 2.4k 0.6× 4.3k 1.4× 2.0k 1.0× 4.4k 2.4× 260 9.9k
Arturo Molina United States 44 1.7k 0.4× 4.6k 1.2× 2.5k 0.8× 1.1k 0.5× 1.2k 0.6× 161 7.8k
Matthew H. Taylor United States 36 687 0.2× 1.6k 0.4× 3.5k 1.1× 1.4k 0.7× 1.4k 0.8× 173 6.4k
David Boulware United States 41 845 0.2× 924 0.3× 1.5k 0.5× 1.6k 0.8× 1.0k 0.6× 122 5.4k
Hagen F. Kennecke Canada 33 1.9k 0.5× 1.4k 0.4× 3.6k 1.2× 1.4k 0.7× 174 0.1× 156 5.5k
Victoria M. Raymond United States 28 2.1k 0.5× 1.2k 0.3× 1.3k 0.4× 716 0.4× 419 0.2× 113 3.4k
Snjezana Doğan United States 31 565 0.1× 1.4k 0.4× 2.0k 0.6× 1.2k 0.6× 1.3k 0.7× 89 4.6k
Renato Martins United States 20 916 0.2× 4.7k 1.3× 4.6k 1.5× 1.7k 0.9× 653 0.4× 42 6.7k
Arun Azad Australia 38 2.1k 0.5× 4.6k 1.3× 2.0k 0.6× 1.4k 0.7× 575 0.3× 261 6.1k
Joaquı́n Mateo United Kingdom 34 1.8k 0.5× 3.2k 0.9× 3.3k 1.0× 2.1k 1.1× 200 0.1× 148 6.1k

Countries citing papers authored by Richard B. Lanman

Since Specialization
Citations

This map shows the geographic impact of Richard B. Lanman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard B. Lanman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard B. Lanman more than expected).

Fields of papers citing papers by Richard B. Lanman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard B. Lanman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard B. Lanman. The network helps show where Richard B. Lanman may publish in the future.

Co-authorship network of co-authors of Richard B. Lanman

This figure shows the co-authorship network connecting the top 25 collaborators of Richard B. Lanman. A scholar is included among the top collaborators of Richard B. Lanman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard B. Lanman. Richard B. Lanman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leighl, Natasha B., Ray D. Page, Victoria M. Raymond, et al.. (2019). Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer. Clinical Cancer Research. 25(15). 4691–4700. 408 indexed citations breakdown →
2.
Maron, Steven B., Leah M. Chase, Samantha Lomnicki, et al.. (2019). Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma. Clinical Cancer Research. 25(23). 7098–7112. 147 indexed citations
3.
Devarakonda, Siddhartha, Sumithra Sankararaman, Brett H. Herzog, et al.. (2019). Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations. Clinical Cancer Research. 25(20). 6119–6126. 41 indexed citations
4.
Rich, Thereasa A., Karen L. Reckamp, Young Kwang Chae, et al.. (2019). Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations. Clinical Cancer Research. 25(19). 5832–5842. 68 indexed citations
5.
Hess, Kenneth R., Filip Jankú, Nora Sánchez, et al.. (2019). Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer. Clinical Cancer Research. 26(8). 1924–1931. 40 indexed citations
6.
Dagogo‐Jack, Ibiayi, Marguerite Rooney, W. Marston Linehan, et al.. (2019). Treatment with Next-Generation ALK Inhibitors Fuels Plasma ALK Mutation Diversity. Clinical Cancer Research. 25(22). 6662–6670. 112 indexed citations
7.
Choi, In Sil, Shumei Kato, Paul T. Fanta, et al.. (2019). Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics. Molecular Cancer Therapeutics. 18(10). 1852–1862. 21 indexed citations
8.
Sonpavde, Guru, Neeraj Agarwal, Gregory R. Pond, et al.. (2019). Circulating tumor DNA alterations in patients with metastatic castration‐resistant prostate cancer. Cancer. 125(9). 1459–1469. 41 indexed citations
9.
Odegaard, Justin I., John J. Vincent, Stefanie Mortimer, et al.. (2018). Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies. Clinical Cancer Research. 24(15). 3539–3549. 283 indexed citations
10.
Maron, Steven B., Lindsay Alpert, Heewon Kwak, et al.. (2018). Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR -Amplified Gastroesophageal Adenocarcinoma. Cancer Discovery. 8(6). 696–713. 79 indexed citations
11.
McCoach, Caroline E., Collin M. Blakely, Kimberly C. Banks, et al.. (2018). Clinical Utility of Cell-Free DNA for the Detection of ALK Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non–Small Cell Lung Cancer. Clinical Cancer Research. 24(12). 2758–2770. 114 indexed citations
12.
Zill, Oliver A., Kimberly C. Banks, Stephen R. Fairclough, et al.. (2018). The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients. Clinical Cancer Research. 24(15). 3528–3538. 271 indexed citations breakdown →
13.
Carneiro, Benedito A., Sahithi Pamarthy, Ami N. Shah, et al.. (2018). Anaplastic Lymphoma Kinase Mutation ( ALK F1174C) in Small Cell Carcinoma of the Prostate and Molecular Response to Alectinib. Clinical Cancer Research. 24(12). 2732–2739. 34 indexed citations
14.
Kato, Shumei, Nithya Krishnamurthy, Kimberly C. Banks, et al.. (2017). Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary. Cancer Research. 77(16). 4238–4246. 90 indexed citations
15.
Strickler, John H., Jonathan M. Loree, Leanne G. Ahronian, et al.. (2017). Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer. Cancer Discovery. 8(2). 164–173. 196 indexed citations
16.
Schwaederlé, Maria, Sandip Pravin Patel, Hatim Husain, et al.. (2017). Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma. Clinical Cancer Research. 23(17). 5101–5111. 118 indexed citations
17.
Hu, Yuebi, Ryan S. Alden, Justin I. Odegaard, et al.. (2017). Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients. Clinical Cancer Research. 23(23). 7351–7359. 63 indexed citations
18.
Croessmann, Sarah, Jonathan H. Sheehan, Kyung‐min Lee, et al.. (2017). PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K α Inhibitors. Clinical Cancer Research. 24(6). 1426–1435. 27 indexed citations
19.
Schwaederlé, Maria, Ranajoy Chattopadhyay, Shumei Kato, et al.. (2017). Genomic Alterations in Circulating Tumor DNA from Diverse Cancer Patients Identified by Next-Generation Sequencing. Cancer Research. 77(19). 5419–5427. 89 indexed citations
20.
Villaflor, Victoria, Rebecca J. Nagy, Kimberly C. Banks, et al.. (2016). Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer. Oncotarget. 7(41). 66880–66891. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lori J. Wirth Breakdown of academic impact, for papers by Arturo Molina Breakdown of academic impact, for papers by Matthew H. Taylor Breakdown of academic impact, for papers by David Boulware Breakdown of academic impact, for papers by Hagen F. Kennecke Breakdown of academic impact, for papers by Victoria M. Raymond Breakdown of academic impact, for papers by Snjezana Doğan Breakdown of academic impact, for papers by Renato Martins Breakdown of academic impact, for papers by Arun Azad Breakdown of academic impact, for papers by Joaquı́n Mateo
Rankless by CCL
2026